Michael Singer, M.D., Ph.D.
Michael Singer is a serial entrepreneur, investor, and ophthalmologist. He has co-founded several life sciences companies, including HealthHonors (sold to Healthways in 2009) and Topokine (sold to Allergan in 2016). Most recently he co-founded Cartesian Therapeutics, a clinical-stage company developing a new generation of Chimeric Antigen Receptor T-cell (CAR-T) products. Mike is also a registered patent agent. He is named as inventor on over 50 issued patents and has written over 25 peer-reviewed scientific papers. Mike completed his B.S. in Biology, Ph.D. in Neuroscience, and M.D. at Yale, followed by internship and residency at Harvard.